Peer-Reviewed Publications

  1. Yanco BG, Nettlow A, Okafor JI, Park JY, and TeStrake D. Comparative antigenic studies of species of Basidiobolus and other medically important fungi. Journal of Clinical Microbiology. 23(4):679-682. 1986 PMID:3084553. PMCID:PMC362815
  2. Ganguly R, and Park JY. Immunostimulating agent against Influenza virus infection in senescent rats. Allergy and Immunology. 34:239-247. 1988 PMID:3228058.
  3. TeStrake D, Park JY, and Yanco BG. Exoantigen comparisons of selected isolates of Basidiobolus species. Mycologia 81(2):284-288, 1989.
  4. Wille JJ, Park JY, and Elgavish A. Effects of growth factors, hormones, bacterial lipopolysaccharide, and lipotechoic acids on the clonal growth of normal urethral epithelial cells in serum-free culture. Journal of Cell Physiology. 150:52-58. 1992 PMID:1730786
  5. Stephensen CB., Blount SR, Schoeb TR and Park JY. Vitamin A deficiency impairs some aspects of host response to influenza A virus infection in BALB/c mice. Journal of Nutrition. 123:823-833. 1993 PMID:8487093
  6. Stephensen CB, Park JY and Blount SR. cDNA sequence analysis confirms that the etiologic agent of Callitrichid Hepatitis is Lymphocytic choriomeningitis virus. Journal of Virology. 69:1349-1352. 1995 PMID:7815520
  7. Park JY, Peters CJ, Rollin PE, Ksiazek TG, Gray G, Waites KB, and Stephensen CB. Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus (LCMV) infection and its use in a prospective surveillance study. Journal of Medical Virology. 51:107-114. 1997 PMID:9021540.
  8. Park JY, Peters CJ, Rollin PE, Ksiazek TG, Katholi CR, Waites KB, GrayB, Maetz HM, and Stephensen CB. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: Evidence of Decreased risk of Infection. American Journal of Tropical Medicine and Hygine. 57(1):37-41. 1997 PMID:9242315.
  9. Park JY, Muscat JE, Ren Q, Schantz SP, Harwick RD, Stern JC, Pike V, Richie JP Jr, and Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prevention 6:791-797. 1997 Erratum in: Cancer Epidemiol Biomarkers Prevention 1997 Dec;6(12):1108. PMID:9332761.
  10. Lazarus P, Sheikh SN, Ren Q, Schantz SP, Stern JC, Richie JP Jr, and Park JY. p53 but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use. Carcinogenesis 19(3):509-514. 1998 PMID:9525287.
  11. Qin GZ, Park JY, Chen SY and Lazarus P. A high prevalence of p53 mutations in premalignant oral erythroplakia. International Journal of Cancer 80:345-348. 1999 PMID:9935172.
  12. Park JY, Schantz SP, Stern JC, Kaur T, and Lazarus P. Association between glutathione S- transferase Pi genetic polymorphisms and oral cancer risk. Phamacogenetics 9:497-504. 1999 Erratum in: Pharmacogenetics 2000 10(4):371. PMID:10780269.
  13. Ren Q, Murphy SE, Dannenberg A, Park JY, Tephly TR, and Lazarus P. Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat UDT-glucuronosyltransferase 2B1. Drug metabolism and Disposition 27:1010-1016. 1999 PMID:10460800.
  14. Park JY, Muscat JE, Kaur T, Schantz SP, Stern JC, Richie JP and Lazarus P. Comparison of GSTM polymorphisms and risk for oral cancer between African Americans and Caucasians. Pharmacogenetics 10:123-131. 2000 PMID:10762000.
  15. Lazarus P and Park JY. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncology 36:421-431. 2000 PMID:10964048.
  16. Liu S, Park JY. Schantz SP, Stern JC and Lazarus P. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncology 37(5):437-445. 2001 PMID:11377232.
  17. Zheng Z., Park JY, Guillemette C, and Lazarus P. The tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. Journal of National Cancer Institute. 93 (18):1411-1418. 2001 PMID:11562393.
  18. Elahi A, Zhong Z, Park JY, Eyring K, McCaffrey T, and Lazarus P The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 23:1229-1234. 2002 PMID:12117782.
  19. Park JY, Schantz SP and Lazarus P. Epoxide hydrolase genotype and orolaryngeal cancer risk: Interaction with GSTM1 genotype. Oral Oncology 39(5): 483-490. 2003 PMID:12747973. PMCID:PMC3715071.
  20. Chen L, Elahi A, Pow-Sang J, Lazarus P and Park JY. Association between polymorphism of human oxoguanine glycosylase 1 (hOGG1) and risk for prostate cancer. The Journal of Urology 170:2471-2474. 2003 PMID:14634453.
  21. Park JY, Chen L, Tockman M, Elahi A., and Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 14:103-109. 2004 PMID:15077011.
  22. Muscat J, Kleinman W, Colosimo S, Muir A, Lazarus P, Park JY, and Richie, JP Jr. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radical Biology and Medicine 36(4):464-470. 2004 PMID:14975449.
  23. Park JY, Chen L, Shade K, Lazarus P, Seigne J, Patterson S., Helal M and Pow-Sang J. Asp85Tyr polymorphism in UDP-glucuronosyltransferase (UGT) 2B15 gene and risk of prostate cancer. Journal of Urology 171(6, Part 1 of 2):2484-2488. 2004 PMID:15126881.
  24. Kim JS, Park JY, Chung WY, Choi MA, Cho KS, and Park KK Polymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitis. Journal of Clinical Periodontology. 31(11):959-964. 2004 PMID:15491310
  25. Park JY, Chen L, Wadhwa N and Tockman MS. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. International Journal of Molecular Medicine 15:443-448. 2005 PMID:15702235.
  26. Park JY, Chen L, Lee JH, Sellers TA and Tockman MS. Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk. Lung Cancer 48:315-321. 2005 PMID:15892999.
  27. Park JY, Chen L, Elahi A, Lazarus P, and Tockman MS. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. European Journal of Cancer Prevention 14(3):223-230. 2005 PMID:15901990.
  28. Park JY, Brena RM, Gruidl M, Zhou J, Huang T, Plass C, and Tockman MS. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Cancer Biomarkers 1(2-3):193-200. 2005 PMID:17192040.
  29. Chen L, Ambrosone CB, Lee JH, Sellers TA, Pow-Sang J. and Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and risk of prostate cancer in white and black Americans. Journal of Urology 175(1):108-112, Discussion 112. 2006 PMID:16406883
  30. Park JY, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, Zachariah B, Heysek RV, Patterson S, and Pow-Sang J. The deletion polymorphism of the UDP-glucuronosyltransferase (UGT) 2B17 and risk of prostate cancer in African American and Caucasians. Cancer Epidemiol Biomarkers Prevention. 15(8):1473-1478. 2006 PMID:16896035.
  31. Cha IH, Park JY, Chung WY, Choi MA, Kim HJ and Park KK. Polymorphism of the CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Medical Journal 48(2): 233-239. 2007 PMID:17461521.
  32. Park JY, Tanner JP, Sellers TA, Huang Y, Stevens CK, Dossett N, Shankar RA, Zachariah B, Heysek R, and Pow-Sang J. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70(2):374-379. 2007 PMID:17826523.
  33. Park JY, Zheng W, Kim DH, Cheng JQ, Kumar N, Ahmad N, and Pow-Sang J. Candidate tumor suppressor gene SLC5A8 is frequently down regulated by promoter hypermethylation in prostate tumor. Cancer Detection and Prevention, 31(5):359-365. 2007 PMID:18037591.
  34. Park JY, Helm JF, Zheng W, Ly Q, Hodul PJ, Centeno BA, and Malafa MP. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. Pancreas, 2008, 36(4):e32-39. PMID:18437076.
  35. Varela-Lema L,Taioli E, Ruano-Ravina A, Barros-Dios JM, Benhamou S, Bhisey RA, Chen CJ, Coutelle C, Foulkes WD, Hayes RB, Katoh T, Lazarus P; Manni JJ, Morita S, Park JY, Roy B, Spitz, MR, Strange RC, Wei Q and Ragin, CC. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genetics in Medicine, 10(6):369-84. 2008 PMID:18496222. PMCID:PMC4036819
  36. Helm J, Centeno BA, Coppola D, Druta M, Park JY, Chen D, Hodul PJ, Kvols L, Yeatman TJ, Carey LC, Karl RC, and Malafa MP. Outcomes following resection of pancreatic adenocarcinoma: 20 years experience at a single institution. Cancer Control, 15(4):288-294. 2008 PMID:18813196.
  37. Evans DE, Park JY, Maxfield N, and Drobes DJ. Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators. Genes, Brain and Behavior, 8(1):86-96. 2009 PMID:19220487.
  38. 38. Park JY, Huang Y, and Sellers TA. Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk. Cancer Epidemiology. Volume 1, Host Susceptibility factors. Methods in Molecular Biology. 471:361-385. 2009 PMID:19109789. PMCID:PMC3968564
  39. 39. Helm J, Centeno BA, Coppola D, Melis M, Lloyd M, Park JY, Chen DT, and Malafa MP. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Cancer, 115(18):4080-4089 2009 PMID:19626671
  40. 40. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dörk T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, Fitzgerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; The UK ProtecT Study Collaborators; The PRACTICAL Consortium, Easton DF. Identification of seven novel prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics, 41(10):1116-1121 2009 PMID: PMCID:PMC2846760
  41. Park JY. Promoter hypermethylation in prostate cancer. Cancer Control, 2010, 17(4):245-255 PMID:20861812. PMCID:PMC3167691

42. Chang B, Spangler E, Gallagher S, Haiman C, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom SA, Ingles S, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki B, Neslund-Dudas C, Kibel AS, Thompson IM, Leach RJ, Ostrander EA, Stanford JL, Witte J, Casey G, Eeles R, Hsing, AW, Chanock S, Hu JJ, John EM, Park JY, Stefflova K, Zeigler-Johnson C,,and Rebbeck TR.  Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent. Cancer Epidemiol. Biomarkers Prev. 20(1): 23-32. 2011 PMID:21071540. PMCID:PMC3110616

  1. Ahn J, Kibel A, Park JY, Rebbeck T, Rennert H, Stanford J., Ostrander E, Chanock S, Wang MH, Mittal RD, Isaacs W, Platz E, and Hayes RB. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clinical Cancer Research, 17:1075-1081. 2011 PMID:21343373. PMCID:PMC3059497
  2. 44. Park JY, Helm JF, Coppola D, Malafa MP, and Kim SJ. microRNAs in pancreatic ductal adenocarcinoma. World Journal of Gastroenterology. 17(7):817-827. 2011 PMID:21412491. PMCID:PMC3051132
  3. Brim H, Kumar K, Nazarian J, Hathout Y, Jafarian A, Lee E, Green W, Smoot D, Park JY, Nouraie M, and Ashktorab H. SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas. PLoS One 6(6):e20216, 2011 PMID:21687703 PMCID:PMC3110579
  4. 46. Rollison DE, Epling-Burnette PK, Park JY, Lee JH, Park H. Jonathan K, Cole AL, Painter JS, Guerrier M, Melendez-Santiago J, Fulp W, Komrokji R, Lancet J, and List AF. Telomere length in myelodysplastic syndromes. Leukemia & Lymphoma. 52(8):1528-1536. 2011 PMID:21635204.
  5. Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Canzian F, Riboli E, Key T, Gronberg H, Hunter D, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Stanford JL, Ostrander EA, Sorensen KD, Dörk T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Frank Gardiner RA, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang HW, Lu YJ, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O’Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, Tiina Wahlfors ED, Tammela TL, Klarskov P, Nordestgaard BG, Røder MA, Tybjærg-Hansen A, Bojesen SE, Travis R, Campa D, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, Fitzgerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin HY, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW , Slavov C, Mitev V, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Easton DF, Eeles RA. Seven Prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics. 43(8):785-791. 2011 PMID:21743467 PMCID:PMC3396006
  6. Yi B, Kasai H, Lee HS, Kang Y, Park JY and Yang M. Inhibition by wheat sprout (Triticum aestivum) juice of bisphenol A induced oxidative stress in young women. Mutation Research. 724(1-2):64-68, 2011, PMID:21736952.
  7. Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell R, Jackson M, Kidd LC, Klob S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, Patrick AL, Rebbeck TR, Romana M, Standord JL, Ukoli F, Vancleave TT, Zeigler-Johnson CM, Mutetwa B and Ragin C. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32(9):1361-1369 2011 PMID:21705483. PMCID:PMC3165127
  8. Lee HS, Park JY and Yang M. Chemopreventive effects of Korean Red Ginseng (Panax ginseng C. A. Meyer) on exposure to polycyclic aromatic hydrocarbons. Journal of Ginseng Research. 35(3):339-343. 2011 PMID:23717078. PMCID:PMC3659533
  9. 51. Lin HY, Park HY, Radlein S, Mahajan N, Sellers TA, Zachariah B, Pow-Sang J, Coppola D, Ganapathy V, and Park JY. Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness. 78(4):971. e1-9. 2011 PMID:21802122. PMCID:PMC3190039
  10. Yang M, Park JY, and Tae K, Genome-wide evidence of XPC alteration in laryngeal squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention. 12:1477-1481. 2011 PMID:22126485
  11. Lin HY, Chen A, Tsai YY, Qu X, Tseng TS and Park JY. TRM: A powerful two-stage machine learning approach for identifying SNP-SNP interactions. The Annals of Human Genetics. 76:53-62. 2012 PMID:22150548 PMCID:PMC3243917
  12. Yang, MH and Park JY. DNA methylation in promoter region and prostate cancer. Methods in Molecular Biology. 863:67-109. 2012 PMID:22359288 PMCID:PMC3715066
  13. Helm J, Coppola D, Ganapathy V, Lloyd M, Centeno BA, Chen D, Malafa MP and Park JY. SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. Pancreas. 41(6): 904-909. 2012 PMID:22450368
  14. Amankwah EK, Sellers TA and Park JY. Gene variants in angiogenesis pathway and prostate cancer. Carcinogenesis. 33(7):1259-69. 2012 PMID:22523086 PMCID:PMC3405650
  15. Jim HS, Park JY, Permuth-Wey J, Rincon, MA, Phillips KM, Small B and Jacobsen P. Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings. Brain, Behavior and Immunity. 26(7):1030-1036 2012 PMID: 22475653 PMCID:PMC3399038
  16. Lee HS, Isse T, Kawamoto T, Woo HS, Kim AK, Park JY and Yang M. Effects and action mechanisms of Korean pears (Pyrus pyrifolia cv. Shingo) on alcohol detoxification. Phytotherapy Research, 26(11): 1753–1758. 2012 PMID:22451246
  17. Wille JJ and Park JY. Retinoid and Ethanol-Sensitive Benzo(α)Pyrene Induction of Cytochrome P450 in Human Keratinocytes. Journal of Cancer Therapy. 3(6):1080-1085. 2012 DOI: 10.4236/jct. 2012.36141
  18. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dörk T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Røder MA, Frikke-Schmidt R, Bojesen SE, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The Australian Prostate Cancer Bioresource; The PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics. 22(2):408-415. 2013 PMID:23065704. PMCID:PMC3526158
  19. 61. Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Krehling J, Plass C, Smiraglia DJ, Tockman M and Kim SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer 79:198-204. 2013 PMID:23273563. PMCID:PMC3566332
  20. Amankwah EK, Anegbe E, Park HY, Pow-Sang J, Hakam A and Park JY. miR-21, miR221 and miR222 expression and prostate cancer recurrence among obese than non-obese cases. Asian Journal of Andrology 15:226-230. 2013 PMID:23353719. PMCID:PMC3705740
  21. Wille JJ and Park JY. Cell cycle arrest mediates global DNA methylation patterns in normal human keratinocytes, epidermoid carcinoma cells and murine embryonic fibroblasts. Journal of Cancer Therapy 2013 4(1):199-207.
  22. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; stralian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics 45(4):385-391. 2013 PMID:23535732 PMCID:PMC3832790
  23. Lin HY, Amankwah, EK, Tseng TS, Qu X, Chen, DT and Park JY. SNP-SNP interaction network in angiogenesis genes associated with prostate cancer aggressiveness. PLoS One 8(4):e59688 2013 PMID:23593148 PMCID:PMC3618555
  24. Park JY, Amankwah E, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Niemeyer K, Marzban, S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina J, Sellers, TA, Sondak, V and Egan, KM. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prevention. 22(5):827-834 2013 PMID:23462921 PMCID:PMC3708315
  25. Lee HS, Isse T, Kawamoto T, Baik HW, Park JY and Yang M. Effect of Korean pear (Pyruspyrifolia cv. Shingo) juice on hangover severity following alcohol consumption Food and Chemical Toxicology 58:101-106 2013 PMID:23587660
  26. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russel R, Dunning AM, Luccarini C, Dennis J, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Marchand LL, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle A, Clements JA, Teixeira MR, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dicks E, Baynes C, Conroy D, Bojesen SE, Kaaks R, Vincent D, Bacot F, Tessier DC; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The PRACTICAL Consortium, Easton DF, Eeles RA. Fine-mapping identifies multiple prostate cancer risk loci on 5p15 some associating with TERT expression. Human Molecular Genetics 22(12):2520-2528 2013 PMID:23535824 PMCID:PMC3658165
  27. Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY, Rollison DE. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiology 37:434-439 2013 PMID:23523330 PMCID:PMC3679277
  28. Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson B, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan C, Ragin C, Roberts R, Rybicki B, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson C. Global patterns of prostate cancer incidence, aggressiveness and mortality in men of African descent. Prostate Cancer volume 2013, article ID 560857 doi:10.1155/2012/560857. 2013 PMID:23476788 PMCID:PMC3583061
  29. Yi B, Kim CS, Han YS, Park MJ, Park JY and Yang MH. Association between endocrine disrupting phenols in colostrums and maternal and infant health. International Journal of Endocrinology. vol. 2013, article ID 282381, doi:10.1155/2013/282381. 2013 PMID:23737772 PMCID:PMC3662185
  30. Chornokur G, Amankwah EK, Davis SN, Phelan CM, Park JY, Pow-Sang J, and Kumar NB. Variation in HNF1B and obesity may influence prostate cancer risk in African American men: a pilot study. Prostate Cancer 2013:384594. PMID: 24386569 PMCID:PMC3872424
  31. Yeo CD, Kim JW, Cho MR, Kang JY, Kim SJ, Kim YK, Lee SH, Park CK, Kim SH, Park MS, Yim HW, and Park JY. Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions. Tuberculosis Respiratory Disease (Seoul). 75(6):244-249. 2013 PMID:24416055 PMCID:PMC3884112
  32. Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Jian G, Rachakonda PS, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, and Newton-Bishop J. An inherited variant in the gene coding for vitamin D binding protein and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Research. 27(2):234-43 doi: 10.1111/pcmr.12193. 2014 PMID:24219834, PMCID:PMC4065372
  33. Lengacher CA, Reich RR, Kip K, Barta, M, Ramesar, S. Paterson, C, Moscoso MS, Carranza I, Budhrani PH, Kim SJ, Park HY, Jacobsen PB, Schell MJ, Jim HS, Post-White J, Farias JR, and Park JY. Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer. Biological Research for Nursing. 16(4):438-47 2014 PMID:24486564
  34. Kim SJ, Amankwah EK, Connors S, Park HY, Rincon M, Cornnell HH, Chornokur G, Ibrahim-Hashim A, Choi J, Tsai YY, Engelman R, Kumar NB,and Park JY. Safety and Chemopreventive effect of Polyphenoc E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prevention Research, 7:435-444. 2014 PMID:24501325 PMCID:PMC4123218
  35. Wille JJ, Burdge JJ, and Park JY. Methods for the Preparation of an Autologous Serum-free Cultured Epidermis and for Autografting Applications. Methods in Molecular Biology. 1195:203-218, 2014 PMID:24500900
  36. Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Severi G, Gronberg H, Aly M, Haiman CA, Schumacher F, Henderson BE, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Nordestgaard BG, Canzian F, Campa D, Riboli E, Key TJ, Travis RC, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Clements JA, Teixeira MR, Xu J, Mikropoulos C, Goh C, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Muir K, Eeles RA, Kote-Jarai Z. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet. 10(2):e1004129. doi:10.1371/journal.pgen. 1004129. eCollection 2014 PMID:24550738 PMCID:PMC3923678
  37. MacQueen DA, Heckman BW, Blank MD, Van Rensburg KJ, Park JY, Drobes DJ, and Evans DE. Variation in the Alpha 5 Nicotinic Acetylcholine Receptor subunit gene predicts cigarette smoking intensity as a function of nicotine Content. Pharmacogenomics Journal 14(1):70-6. 2014 PMID:23358500 PMCID:PMC3778124
  38. Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Rachakonda PS, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Bishop DT, Newton-Bishop J. Inherited variation in the PARP-1 gene and survival from melanoma. International Journal of Cancer. 135:1625-1633. 2014 PMID:24535833. PMCID:PMC4106984
  39. Long Q, Xu J, Osunkoya AO, Sannigrahi S, Johnson BA, Zhou W, Gillespie T, Park JY, Nam RK, Sugar L, Stanimirovic A, Seth AK, Petros JA, and Moreno CS. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Research 74(12):3228-3237. 2014 PMID:24713434 PMCID:PMC4058362
  40. Wille JJ and Park JY. Effects of okadaic acid, retinoic acid and phorbol myristate acetate tumor promoter on oncogene expression. Journal of Cancer Therapy. 5(6):591-604 2014
  41. Ragin C and Park JY Biospecimens, Biobanking and Global Cancer Research Collaborations. eCancer Medical Science 8:454. 2014 PMID:25228910 PMCID:PMC4154946
  42. Evans DE, MacQueen DA, Jentink, KG, Park JY, Lin HY and Drobes DJ. CHRNA5-variants moderate the effect of Nicotine Deprivation on a Neural index of Cognitive Control. Genes, Brain and Behavior 13(7):626-632. 2014 PMID:24934182 PMCID:PMC4178975
  43. Carastro LM, Lin HY, Park HY, Kim DH, Radlein S, Hampton KK, Hakam A, Zachariah B, Pow-Sang J, and Park JY. Role of p73 di-nucleotide polymorphism in prostate cancer and p73 protein isoform balance. Prostate Cancer. 2014:129582. doi: 10.1155/2014/129582. Epub 2014 Jul 6. 2014 PMID:25097786 PMCID:PMC4109114
  44. Tseng TS, Park JY, Zabaleta J, Moody-Thomas S, Sothern MS, Chen T, Evans DE, and Lin HY. Role of nicotine dependence on the relationship between genetic variants and risk of lung adenocarcinoma PLoS One 9(9):e107268 2014 PMID:25233467, PMCID:PMC4169410
  45. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Røder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokołorczyk D, Kluźniak W, Park JY, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G; The Breast and Prostate Cancer Cohort Consortium (BPC3); The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; The COGS (Collaborative Oncological Gene-environment Study) Consortium; The GAME-ON/ELLIPSE Consortium, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics. 46(10):1103-1109. 2014 PMID:25217961
  46. Hale T, Weischer M, and Park JY. CHEK2*1100delC mutation and risk of prostate cancer. Prostate Cancer. volume 2014:294575, 2014 PMID:25431674
  47. Gallaher J, Cook LM, Gupta S, Araujo A, Dhillon J, Park JY, Scott JG, Pow-Sang J, Basanta D and, Lynch CC. Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling. Clinical & Experimental Metastasis. 31(8):991-9. 2014 PMID:25173680.
  48. Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, John EM, Kibel AS, Klein EA, Kolb S, Marchand LL, Leske MC, Murphy AB, Neslund-Dudas C, Park JY, Pettaway C, Rebbeck TR, Gapstur SM, Zheng SL, Wu SY, Witte JS, Xu J, Isaacs W, Ingles SA, Hsing A; The PRACTICAL Consortium; The ELLIPSE GAME-ON Consortium, Easton DF, Eeles RA, Schumacher FR, Chanock S, Nemesure B, Blot WJ, Stram DO, Henderson BE, Haiman CA. Generalizability of established prostate cancer risk variants in men of African-ancestry. International Journal of Cancer 2015 Mar 1;136(5):1210-7 PMID:25044450 PMCID:PMC4268262
  49. Lengacher CA, Reich RR, Jim H, Ramesar, S. Budhrani P, Paterson CL, Farias JR, Shelton M, Moscoso, M, Park JY and Kip KE, The effect of Mindfulness based stress reduction (MBSR(BC)) on sleep quality in women with breast cancer: A randomized controlled trial. Psychooncology. 2015 24(4):424-32. PMID:24943918
  50. Na HK, Kim M, Chang SS, Kim SY, Park JY, Chung MW, and Yang M, Tobacco Smoking-Response Genes in Blood and Buccal Cells. Toxicology Letters 232(2):429-437 2015 PMID:25447457
  51. Lee I, Tran M, Evans-Nguyen T, Stickle D, Kim S, Han J, Park JY, and Yang M. Detoxification of Chlorella supplement on Heterocyclic Amines in Korean Young Adults. Environmental Toxicology and Pharmacology 2015 39(1):441-446. PMID: 25590673
  52. Park JY. Promoter hypermethylation as a biomarker in prostate adenocarcinoma. Methods in Molecular Biology;1238:607-25. 2015 PMID: 25421683
  53. Stegeman S, Amankwah EK, Klein K, O’Mara T, Kim DH, Lin HY, Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Ali Amin Al Olama, Sara Benlloch, Kenneth Muir, Graham Giles, Wiklund F, Gronberg H, Haiman C, Schleutker J, Weischer M, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau C, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, PRACTICAL Consortium, Australian Prostate Cancer BioResource, Spurdle AB, Clements JA, Park JY*, and Batra J. Genome-wide association studies of miRSNPs identify novel functional prostate cancer risk SNPs. Cancer Discovery 2015 5(4):368-79 PMID: 25691096
  54. Gonzalez BD, Jim HS, Donovan KA, Small BJ, Sutton SK, Park JY, Lin HY, Spiess PE, Fishman MN, and Jacobsen PB. Course and Moderators of Hot Flash Interference During Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison. 2015 Journal of Urology. 194(3):690-5. PMID: 25791402
  55. Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal D, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman C, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney K, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prevention. 2015 24(7):1121-9. PMID: 25837820
  56. Lengacher CA, Reich RR. Kip KE, Paterson CL, Park HY, Ramesar S, Jim HS, Alinat CB, and Park JY. Moderating Effects of Genetic Polymorphisms on Improvements in Cognitive Impairment in Breast Cancer Survivors Participating in a 6-week Mindfulness-Based Stress Reduction Program. Biological Research for Nursing 2015. 17(4):393-404. PMID: 25882604
  57. Gonzalez BD, Jim HS, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, and Jacobsen PB. Course and Predictors of Cognitive Function in Prostate Cancer Patients Receiving Androgen Deprivation Therapy: A Controlled Comparison. 2015 Journal of Clinical Oncology. 33(18):2021-7. PMID: 25964245, PMCID: PMC4461804.
  58. Kang N, Choi ST, Kim YK, Yoo IR, Han DH, Lee DS, Kim YS, Hong SH, Kang JH, Lee KY, Park JK, Sung SW, Park, MS, Yim HW, Kim SJ and Park JY. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer. 2015 Lung Cancer, 89(2):99-103. PMID: 26101014.
  59. Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokołorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; Australian Prostate Cancer BioResource; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. 2015 Human Molecular Genetics. 24(19):5589-602. PMID: 26025378.
  60. Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubiński J, Kluźniak W, Cannon-Albright L, Brenner H, Butterbach K, Stegmaier C, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, BioResource TA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Consortium TP, Gronberg H, Wiklund F. Prediction of individual genetic risk to prostate cancer using a polygenic score. 2015. Prostate. 2015 Sep;75(13):1467-1474. PMID: 26177737
  61. 103. Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald L, Henderson BE, Schumacher FR, Haiman CA, Sipeky C, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal D, Donovan JL, Hamdy FC, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubinski J, Kluzniak W, Cannon-Albright L, Brenner H, Herrmann V, Holleczek B, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva RP, Mitev VI, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha HS, Michael A, Kierzek A, Albanes D, Andriole GL, Berndt SI, Chanock SJ, Gapstur SM, Giovannucci EL, Hunter DJ, Kraft P, Le Marchand L, Ma J, Mondul AM, Penney KL, Stampfer M, Stevens VL, Weinstein SJ, Trichopoulou A, Bueno-de-Mesquita HB, Tjonneland A, Cox DG, Maehle L, Schleutker J, Lindstrom S, Wiklund F. Genome-Wide Association Study of Prostate Cancer-Specific Survival. Cancer Epidemiol Biomarkers Prevention. 2015 24(11):1796-800. PMID: 26307654
  62. Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL consortium, Lathrop M, Smith GD, Martin RM. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. 2015 Cancer Causes and Control. 26(11):1603-16. PMID: 26387087
  63. Yang M, Youn JI, Kim SJ, and Park JY. Epigenetic Modulation of Chlorella (Chlorella vulgaris) on Exposure to Polycyclic Aromatic Hydrocarbons. 2015 Environmental Toxicology and Pharmacology. 40(3):758-763. PMID:26432772
  64. 106. Harrell P, Lin HY, Park JY, Blank M, Drobes DJ, and Evans DE. Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward. Psychopharmacology 2016 233(2):351-60. PMID: 26497691
  65. Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG, Wiklund F, Grönberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. British Journal of Cancer. 2016 114(8):945-52. PMID: 26964030
  66. 108. Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OH, Richards JB, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, MacInnis RJ, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Micheal A, Pandha H, Smith GD, Lewis SJ, Martin RM; PRACTICAL consortium. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Medicine. 2016 5(6):1125-36. PMID: 26992435
  67. Wu ES, Park JY, Zeitouni J, Gomez CR, Reis IM, Zhao W, Kwon D4, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, and Hu JJ. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis. Head and Neck 2016 38(8):1234-41. PMID: 27028310
  68. Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, Carpten J, Leske MC, Wu SY, Hennis AJ, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Witte JS, Casey G, Kaggwa S, Cook MB, Stram DO, Blot WJ, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Gronberg H, Wiklund F, Aly M, Henderson BE, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Teerlink C, Brenner H, Dieffenbach AK, Arndt V, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA, Teixeira MR, Pandha H, Michael A, Paulo P, Maia S, Kierzek A; PRACTICAL consortium, Conti DV, Albanes D, Berg C, Berndt SI, Campa D, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giovannucci E, Hoover R, Hunter DJ, Johansson M, Kraft P, Le Marchand L, Lindström S, Navarro C, Overvad K, Riboli E, Siddiq A, Stevens VL, Trichopoulos D, Vineis P, Yeager M, Trynka G, Raychaudhuri S, Schumacher FR, Price AL, Freedman ML, Haiman CA, Pasaniuc B. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature Communications 2016 PMID: 27052111 PMCID: PMC4829663
  69. Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Davey Smith G; PRACTICAL consortium. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC Medicine 2016 14(1):66. PMID: 27044414 PMCID: PMC4820939
  70. Lengacher CA, Reich, RR, Paterson CL, Ramesar S, Park JY, Alinat C, Johnson-Mallard V, Moscoso M, Budhrani PH, Miladinovic B, Jacobsen PB, Cox CE, Goodman M, and Kip KE. Examination of Broad Symptom Improvement Resulting From Mindfulness-Based Stress Reduction in Breast Cancer Survivors: A Randomized Controlled Trial. Journal of Clinical Oncology. 2016 34(24):2827-34. PMID: 27247219
  71. Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Smith GD, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL consortium, Lathrop M, Martin RM, Holly JM. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: genetic variants as instruments for circulating levels. International Journal of Cancer. 2016 139(7):1520-33. PMID: 27225428
  72. Das DK, Osborne JR, Lin HY, Park JY*, and Ogunwobi OO, miR-1207-3p is a novel prognostic biomarker of prostate cancer. Translational Oncology. 2016 9(3):236-41. PMID: 27267842
  73. Evans DE, Sutton S, Jentink KG, Lin HY, Park JY, and Drobes DJ, Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Indices of Cognitive Disruption during Nicotine Withdrawal. Genes Brain and Behavior 2016 15:621–626 PMID: 27453054
  74. Pinheiro WO, Marques CR, Rios-Santos F, Fernandes MDB, Santos DB, Klein SOT, Oliveira FS, Gonzales A, Freitas DC, Park JY, and Di Pietro G. Association of the lipoprotein lipase S447X and neuropeptide Y Leu7Pro genetic polymorphisms with the lipid profiles of individuals with and without evidence of coronary artery disease. British Journal of Medicine & Medical Research 2016 16(5):1-10.
  75. Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ; ABCTB Investigators, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, Gentry-Maharaj A, Whittemore AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A; AOCS Study Group & Australian Cancer Study (Ovarian Cancer); APCB BioResource, Ziogas A, Ekici AB, Burwinkel B, Karlan BY, Nordestgaard BG, Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Stegmaier C, Maier C, Ambrosone CB, Høgdall CK, Teerlink CC, Kang D, Tessier DC, Schaid DJ, Stram DO, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, Høgdall E, Song F, Bruinsma F, Heitz F, Modugno F, Hamdy FC, Wiklund F, Giles GG, Olsson H, Wildiers H, Ulmer HU, Pandha H, Risch HA, Darabi H, Salvesen HB, Nevanlinna H, Gronberg H, Brenner H, Brauch H, Anton-Culver H, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, Lubiński J, Stanford JL, Benítez J, Doherty JA, Permuth JB, Chang-Claude J, Donovan JL, Dennis J, Schildkraut JM, Schleutker J, Hopper JL, Kupryjanczyk J, Park JY, Figueroa J, Clements JA, Knight JA, Peto J, Cunningham JM, Pow-Sang J, Batra J, Czene K, Lu KH, Herkommer K, Khaw KT; kConFab Investigators, Matsuo K, Muir K, Offitt K, Chen K, Moysich KB, Aittomäki K, Odunsi K, Kiemeney LA, Massuger LF, Fitzgerald LM, Cook LS, Cannon-Albright L, Hooning MJ, Pike MC, Bolla MK, Luedeke M, Teixeira MR, Goodman MT, Schmidt MK, Riggan M, Aly M, Rossing MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Lush M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N; NBCS Investigators, Le ND, Orr N, Wentzensen N, Pashayan N, Peterlongo P, Guénel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud RK, Schmutzler RK, Stephenson RA, MacInnis RJ, Hoover RN, Winqvist R, Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell SK, Tworoger SS, Maia S, Berndt S, Lee SC, Teo SH, Thibodeau SN, Bojesen SE, Gapstur SM, Kjær SK, Pejovic T, Tammela TL; GENICA Network; PRACTICAL consortium, Dörk T, Brüning T, Wahlfors T, Key TJ, Edwards TL, Menon U, Hamann U, Mitev V, Kosma VM, Setiawan VW, Kristensen V, Arndt V, Vogel W, Zheng W, Sieh W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman ML, Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, Gayther SA, Easton DF, Chenevix-Trench G, Eeles R, Pharoah PD, Lambrechts D. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. 2016 6(9):1052-67. PMID: 27432226
  76. Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. BMC Cancer 2016 16(1):557, PMID: 27473687. PMCID:PMC4966583
  77. Wille JJ and Park JY. Enhancement of Clonal Growth of Normal Human Keratinocytes in a Serum-free Medium by Lithium Ions, Dibutryl-Cyclic AMP and Prostaglandin E1. 2016 Global Dermatology 3(5): 374-378,
  78. Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guénel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menéndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Brüning T, Ko YD, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K; Australian Ovarian Cancer Study Group, Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnæs GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila S, Devilee P, Tollenaar RA, Seynaeve C, Hollestelle A, Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens JW, Collée JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres D, Ulmer HU, Rüdiger T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A, Ashworth A, Orr N, Jones M, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Butterbach K, Park JY, Kaneva R, Batra J, Teixeira MR, Kote-Jarai Z, Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A, Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K, Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Edwards RP, Ness RB, Moysich KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Høgdall E, Peissel B, Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer M, Tworoger SS, Bandera EV, Orlow I, Olson SH, Bjorge L, Salvesen HB, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Górski B, Gronwald J, Menkiszak J, Høgdall CK, Lundvall L, Nedergaard L, Engelholm SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Song H, Winship I, Chenevix-Trench G, Giles GG, Tavtigian SV, Easton DF, Milne RL. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. 2016 53(12):800-811 pii: jmedgenet-2016-103839. doi: 10.1136/jmedgenet-2016-103839. PMID: 27595995
  79. Wille JJ, and Park JY. Induced differentiation of epithelioid carcinoma cell lines: Evidence for tumor cell quantal mitosis. Journal of Cancer Therapy 2016 7(10):794-811.
  80. Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Donovan JL, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zheng W; PRACTICAL consortium. Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. British Journal of Cancer 115(5):624-31 2016 PMID: 27490808
  81. Das DK, Naidoo M, Ilboudo A, Park JY, Ali T, Krampis K, Robinson BD, Osborne JR, Ogunwobi OO. miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin. 2016. 348(2):190-200. Experimental Cell Research. PMID: 27693493, PMCID: PMC5077722
  82. Kumar NB, Pow-Sang J, Spiess PE, Park JY, Chornokur G, Leone AR and Phelan CM. Chemoprevention in African American men with prostate cancer. Cancer Control. 2016 23(4):415-423. PMID: 27842331
  83. Lin HY, Cheng CH, Chen DT, Chen YA and Park JY. Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer. Translational Cancer Research 2016 5(Suppl 5):S951-S963.
  84. 126. Di Pietro G, Chornokur G, Kumar NB, Davis C, and Park JY. Racial differences in Diagnosis and Treatment of Prostate Cancer. 2016 International Neurourology Journal 20(Suppl 2):S112-119. PMID: 27915474.
  85. 127. Wille JJ, Park JY and Shealy, YF. Cancer Chemopreventive Retinoids: Validation and Analysis of In Vivo and In Vitro Bioassay Results. ‘Cancer Causes and Prevention’ Special Edition, 2016 Journal of Cancer Therapy 7:1008-1033.
  86. Wille JJ, Burdge JJ, and Park JY. Wound Healing of Chronic Leg Ulcers Is Stimulated by Wound Edge Continuity with Adult Cultured Epidermal Autografts. 2016 MOJ Cell Science & Report 3(5):69-75
  87. Kumar NB, Pow-Sang J, Spiess PE, Park J, Salup R, Williams CR, Parnes H, Schell MJ. Randomized, Placebo-Controlled Trial Evaluating the Safety of One-Year Administration of Green Tea Catechins. Oncotarget 2016 7(43):70794-70802. PMID: 28053292
  88. Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Donovan J, Hamdy FC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL Consortium, Collins A, Zuccolo L. Alcohol Consumption and Prostate Cancer Incidence and Progression: a Mendelian Randomisation Study. International Journal of Cancer 2017 140(1), pg 75-85. PMID: 27643404, PMCID: PMC5111609
  89. Reich RR, Lengacher CA, Alinat CB, Kip KE, Paterson C, Ramesar S, Han HS, Ismail-Khan R, Johnson-Mallard V, Moscoso M, Budhrani-Shani P, Shivers S, Cox CE, Goodman M, Park JY. Mindfulness-Based Stress Reduction in Post-Treatment Breast Cancer Patients: Immediate and Sustained Effects across Multiple Symptom Clusters. Journal of Pain and Symptom Management 2017;53(1):85-95. PMID: 27720794
  90. Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Blot W, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL Consortium, Donovan J, Munafò MR. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. 2017 International Journal of Cancer 140(2):322-328. PMID: 27741566, PMCID: PMC5132137.
  91. Strand SH, Switnicki M, Moller M, Haldrup C, Storebjerg TM, Hedegaard J, Nordentoft I, Hoyer S, Borre M, Pedersen JS, Wild PJ, Park JY, Orntoft TF, Sorensen KD. RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. 2017 Oncotarget 24;8(4):5774-5788. PMID: 28052017
  92. Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM, Cheng CH, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Batra J, Teixeira MR, Pandha H, Lu YJ; PRACTICAL Consortium., Park JY.SNP Interaction Pattern Identifier (SIPI): an Intensive Search for SNP-SNP Interaction Patterns. Bioinformatics 33(6):822-833 2017 PMID: 28039167
  93. Mukhtar F, Boffetta P, Risch HA, Park JY, Bubu OM, Womack L, Tran TV, Zgibor JC, Luu HN.. Survival predictors of burkitt’s lymphoma in children, adults and elderly in the United States during 2000-2013. 2017 International Journal of Cancer 140: (7) 1494-1502 PMID: 28006853
  94. Webber TA, Soder HE, Potts GF, Park JY, Bornovalova MA. Neural outcome processing of peer-influenced risk-taking behavior in late adolescence: Preliminary evidence for gene × environment interactions. Experimental and Clinical Psychopharmacology. 2017;25(1):31-40. PMID: 28150970
  95. 137. Lee HS, Kang Y, Tae K, Bae GU, Park JY, Cho YH, and Yang Proteomic Biomarkers for Bisphenol A-Early Exposure and Women's Thyroid Cancer. Cancer Research and Treatment 2017 Mar 8. doi: 10.4143/crt.2017.001. [Epub ahead of print] PMID: 28279065.
  96. Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, Kang N, Kim SJ, Park JY*, Di Pietro G. miRNAs associated with prostate cancer risk and progression. 2017 BMC Urology 17(1):18. PMID: 28320379, PMCID: PMC5359825.
  97. Reich RR, Lengacher CA, Klein TW, Newton C, Shivers S, Ramesar S, Alinat CB, Paterson C, Le A, Park JY, Johnson-Mallard V, Elias M, Moscoso M, Goodman M, Kip KE. A Randomized Controlled Trial of the Effects of Mindfulness-Based Stress Reduction (MBSR[BC]) on Levels of Inflammatory Biomarkers Among Recovering Breast Cancer Survivors. 2017 Biological Research for Nursing PMID: 28460534.

In press/Accepted

  1. David V. Conti1, Kan Wang1, Xin Sheng1, Jeannette T. Bensen2, 3, Dennis J. Hazelett4, Michael B. Cook5, Sue A. Ingles1,6, Rick A. Kittles7, Sara S. Strom8, Benjamin A. Rybicki9, Barbara Nemesure10, William B. Isaacs11, Janet L. Stanford12, 13, Wei Zheng14, Maureen Sanderson15, Esther M. John16, 17, Park JY, Jianfeng Xu19, Victoria L. Stevens20, Sonja I. Berndt5, Chad D. Huff8, Zhaoming Wang21, Edward D. Yeboah22, 23, Yao Tettey22, 23, Richard B. Biritwum22, 23, Andrew A. Adjei22, 23, Evelyn Tay22, 23, Ann Truelove24, Shelley Niwa24, Thomas A. Sellers18, Kosj Yamoah25, Adam B. Murphy26, Dana C. Crawford27, Susan M. Gapstur20, William S. Bush27, Melinda C. Aldrich28, Olivier Cussenot29, Gyorgy Petrovics30, Jennifer Cullen30, Christine Neslund-Dudas9, Mariana C. Stern1, 6, Zsofia Kote-Jarai31, Koveela Govindasami32, Anand P. Chokkalingam33, Ann W. Hsing16, Phyllis J. Goodman34, Thomas Hoffmann35, Bettina F. Drake36, Jennifer J. Hu37, Peter E. Clark38, Stephen K. Van Den Eeden39, Pascal Blanchet40, Jay H. Fowke41, Graham Casey42, Anslem J.M. Hennis10, 43, Ying Han1, Alex Lubwama44, Ian M. Thompson, Jr45, Robin Leach45, Douglas F. Easton46, Fredrick Schumacher47, David J. Van den Berg1, Susan M. Gundell1, Alex Stram1, Peggy Wan1, Lucy Xia1, Loreall C. Pooler1, James L. Mohler3,48, Elizabeth T.H. Fontham49, Gary J. Smith48, Jack Taylor50, 51, Shiv Srivastava30, Rosalind A. Eeles31, 52, John Carpten53, Adam S. Kibel54, 55, Luc Multigner56, Marie-Elise Parent57, Florence Menegaux58, Geraldine Cancel-Tassin29, Eric A. Klein59, Laurent Brureau40,  Daniel O. Stram1, 6, Stephen Watya44, 60, Stephen J. Chanock5, John S. Witte35, 61, William J. Blot14, PRACTICAL/ELLIPSE62, Brian E. Henderson1, 6*, Christopher A. Haiman1, 6** Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. 2017 Journal of National Cancer Institute

Revision Requested

  1. Cecile A. Lengacher, Richard R. Reich, Carissa B. Alinat, Sophia Ramesar, Maya N. Elias, Lakeshia Cousin, Manolete Moscoso, Carly L. Paterson, Kevin E. Kip, Hongdao Meng, Park JY. Feasibility of the Mobile Mindfulness-Based Stress Reduction for Breast Cancer (mMBSR(BC)) Program for Symptom Improvement among Breast Cancer Survivors. 2017 Psycho-Oncology
  2. Tokhir Dadaev1,†, Edward J. Saunders1,†, Paul Newcombe2, Ezequiel  Anokian1,  Daniel Leongamornlert1,  Mark N. Brook1,  Clara Cieza-Borrella1,  Martina Mijuskovic1,  Sarah Stephens1,  Ali Amin Al Olama1,4,  Fredrick R. Schumacher3,6,  Sonja I. Berndt5,  Sara Benlloch7,1,  Mahbubl Ahmed3,  Chee Goh1,  Xin Sheng8,  Kenneth Muir9,10,  Koveela Govindasami1,  Artitaya Lophatananon9,10,  Victoria L. Stevens11,  Susan M. Gapstur11,  Brian D. Carter11,  Catherine M. Tangen12,  Phyllis Goodman12,  Ian M. Thompson Jr.13,  Jyotsna Batra14,15,  APCB BioResource14,  Suzanne Chambers16,17,  Leire Moya14,15,  Judith Clements14,15,  Lisa Horvath18,19,  Wayne Tilley20,  Gail Risbridger21,  Henrik Gronberg22,  Markus Aly22,23,  Tobias Nordström22,24,  Paul Pharoah25,  Nora Pashayan26,25,  Johanna Schleutker27,28,29,  Teuvo LJ Tammela30,  Csilla Sipeky27,  Anssi Auvinen31,  Demetrius Albanes7,  Stephanie Weinstein7,  Alicja Wolk32,  Niclas Hakansson32,  Catharine West33,  Alison M. Dunning25,  Neil Burnet34,  Lorelei Mucci35,  Edward Giovannucci35,  Gerald Andriole36,  Olivier Cussenot37,  Géraldine Cancel-Tassin38,37,  Stella Koutros7,  Laura E. Beane Freeman7,  Karina Dalsgaard Sorensen39,40,  Torben Falck Orntoft39,40,  Michael Borre41,40,  Lovise Maehle42,  Eli Marie Grindedal42,  David E. Neal43,44,  Jenny L. Donovan45, Freddie C. Hamdy46,  Richard M. Martin45,  Ruth C. Travis47,  Tim J. Key47,  Robert J. Hamilton48,  Neil E. Fleshner48,  Antonio Finelli48,  Sue Ann Ingles8,  Mariana C. Stern8,  Barry Rosenstein49,50,  Sarah Kerns51,  Harry Ostrer52,  Yong-Jie Lu53,  Hong-Wei Zhang 54,  Ninghan Feng55,  Xueying Mao53,  Xin Guo56,  Guomin Wang57,  Zan Sun58,  Graham G. Giles59,60,  Melissa C. Southey61,  Robert J. MacInnis59,60,  Liesel M Fitzgerald62,59,  Adam S. Kibel63,  Bettina Drake36,  The IMPACT Study Steering Committee64,  Ana Vega65,  Antonio Gómez-Caamaño66,  Robert Szulkin67,68,  Martin Eklund22,  Manolis Kogevinas69,70,71,72,  Javier Llorca73,70,  Gemma Castaño-Vinyals69,70,71,72,  Kathryn L. Penney74,  Meir Stampfer74, Park JY,  Thomas A. Sellers75,  Hui-Yi Lin76,  Janet L. Stanford77,78,  Cezary Cybulski79,  Dominika Wokolorczyk79,  Jan Lubinski79,  Elaine A. Ostrander80,  Milan Geybels77,  Børge G. Nordestgaard81,82,  Sune F. Nielsen81,82,  Maren Weisher82,  Rasmus Bisbjerg83,  Martin Andreas Røder84,  Peter Iversen81,84,  Hermann Brenner85,86,87,  Katarina Cuk85,  Bernd Holleczek88,  Christiane Maier89,  Manuel Luedeke89,  Thomas Schnoeller90,  Jeri Kim91,  Christopher J. Logothetis91,  Esther M. John92,93,  Manuel R. Teixeira94,95,  Paula Paulo94,  Marta Cardoso94,  Susan L. Neuhausen96,  Linda Steele96,  Yuan Chun Ding96,  Kim De Ruyck97,  Gert De Meerleer97,  Piet Ost98,  Azad Razack99,  Jasmine Lim99,  Soo-Hwang Teo100,  Daniel W. Lin77,101,  Lisa F. Newcomb77,101,  Canary PASS Investigators77,101,  Davor Lessel102,  Marija Gamulin103,  Tomislav Kulis104,  Radka Kaneva105,  Nawaid Usmani106,107,  Chavdar Slavov108,  Vanio Mitev105,  Matthew Parliament106,107,  Frank Claessens109,  Steven Joniau110,  Thomas Van den Broeck109,110,  Samantha Larkin111,  Paul A. Townsend112,  Claire Aukim-Hastie113,  Manuela Gago Dominguez114,115,  Jose Esteban Castelao116,  Maria Elena Martinez117,  Monique J. Roobol118,  Guido Jenster118,  Ron H.N. van Schaik119,  Florence Menegaux120,  Thérèse Truong120,  Yves Akoli Koudou 120,  The Profile Study Steering Committee121,  Jianfeng Xu122,  Kay-Tee Khaw123,  Lisa Cannon-Albright124,125,  Hardev Pandha113,  Agnieszka Michael113,  Andrzej Kierzek113,  Stephen N. Thibodeau126,  Shannon K. McDonnell127,  Daniel J. Schaid127,  Sara Lindstrom128,  Constance Chen129,  Jing Ma74,  David J. Hunter129,  Elio Riboli130,  Afshan Siddiq131,  Federico Canzian132,  Laurence N. Kolonel133,  Loic Le Marchand133,  Robert N. Hoover7,  Mitchell J. Machiela7,  Peter Kraft129,  BPC3 (Breast and Prostate Cancer Cohort Consortium)134,  The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium134,  CAPS (Cancer of the Prostate in Sweden)134,  PEGASUS (Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci)134,  Matthew Freedman134,  The GAME-ON/ELLIPSE Consortium135,  Fredrik Wiklund22,  Stephen Chanock7,  Brian E.  Henderson8,  Douglas F. Easton3,  Christopher A. Haiman8,††,  Rosalind A. Eeles1,136,††,  David V. Conti8,††,  ZSofia Kote-Jarai1,††.  Fine-mapping of Prostate Cancer Susceptibility Loci in a Large Meta-Analysis Identifies Candidate Causal. 2017 Nature Communications  
  3. Fredrick R. Schumacher1,2†, Ali Amin Al Olama3†, Sonja I. Berndt4†, Sara Benlloch3,5, Mahbubl Ahmed5, Edward J. Saunders5, Tokhir Dadaev5, Daniel Leongamornlert5, Ezequiel Anokian5, Clara Cieza-Borrella5, Chee Goh5, Xin Sheng6, Laura Fachal3, Joe Dennis3, Jonathan Tyrer3, Kenneth Muir7,8, Artitaya Lophatananon7,8, Victoria L. Stevens9, Susan M. Gapstur9, Brian D. Carter9, Catherine M. Tangen10, Jyotsna Batra11,12, APCB BioResource11, Suzanne Chambers13,14, Leire Moya11,12, Henrik Gronberg15, Markus Aly15, Tobias Nordström15,16, Paul Pharoah17, Nora Pashayan17,18, Johanna Schleutker19-21, Teuvo LJ Tammela22, Csilla Sipeky19, Demetrius Albanes23, Stephanie Weinstein23, Alicja Wolk24, Niclas Hakansson24, Catharine West25, Alison Dunning17, Neil Burnet26, Lorelei Mucci27, Edward Giovannucci27, Gerald Andriole28, Olivier Cussenot29, Géraldine Cancel-Tassin30, Stella Koutros23, Laura E. Beane-Freeman23, Karina Dalsgaard Sorensen31,32, Torben Falck Orntoft31,32, Michael Borre32,33, Lovise Maehle34, Eli Marie Grindedal34, David E. Neal35,36, Jenny L. Donovan37, Freddie C. Hamdy38, Richard Martin37, Ruth C. Travis39, Tim J. Key39, Robert J. Hamilton40, Neil E. Fleshner40, Antonio Finelli40, Sue Ann Ingles6, Mariana C. Stern6, Barry Rosenstein41,42, Sarah Kerns43, Harry Ostrer44, Yong-Jie Lu45, Hong-Wei Zhang46, Ninghan Feng47, Xueying Mao45, Xin Guo48, Guomin Wang49, Zan Sun50, Graham G. Giles51,52, Melissa C. Southey53, Robert MacInnis51,52, Adam S. Kibel54, Bettina Drake28, IMPACT55, Ana Vega56, Antonio Gómez-Caamaño57, Robert Szulkin15, Martin Eklund15, Manolis Kogevinas58-61, Javier Llorca Diaz59,62, Gemma Castaño-Vinyals58-61, Kathryn L. Penney63, Meir Stampfer63, Park JY, Thomas A. Sellers64, Hui-Yi Lin65, Janet L. Stanford66,67, Cezary Cybulski68, Dominika Wokolorczyk68, Jan Lubinski68, Elaine A. Ostrander69, Milan Geybels66, Børge G. Nordestgaard32,70, Sune F. Nielsen32,70, Hermann Brenner71-73, Katarina Cuk71, Holleczek Berndt74, Christiane Maier75, Manuel Luedeke75, Thomas Schnoeller75, Jeri Kim76, Christopher J. Logothetis76, Esther M. John77,78, Manuel R. Teixeira79, Paula Paulo79, Marta Cardoso79, Susan L. Neuhausen80, Linda Steele80, Yuan Chun Ding80, Kim De Ruyck81, Gert De Meerleer82, Piet Ost82, Azad Razack83, Jasmine Lim83, Soo-Hwang Teo84, Daniel W. Lin66,85, Lisa F. Newcomb66,85, Canary PASS Investigators66,85, Davor Lessel86, Marija Gamulin87, Tomislav Kulis88, Radka Kaneva89, Nawaid Usmani90,91, Chavdar Slavov92, Vanio Mitev93, Matthew Parliament90,91, Frank Claessens94, Steven Joniau95, Thomas Van den Broeck94,96, Samantha Larkin97, Paul A. Townsend98, Claire Aukim-Hastie99, Manuela Gago Dominguez100, Jose Esteban Castelao101, Elena Martinez102, Monique J. Roobol103, Guido Jenster103, Ron H.N. van Schaik104, Florence Menegaux105, Thérèse Truong105, The Profile Study Steering Committee106, Jianfeng Xu107, Kay-Tee Khaw108, Lisa Cannon-Albright109,110, Hardev Pandha111, Agnieszka Michael111, Andrzej Kierzek111, Stephen N. Thibodeau112, Shannon K. McDonnell113, Daniel J. Schaid113, Sara Lindstrom114, Constance Chen115, Jing Ma63, David J. Hunter115, Elio Riboli116, Afshan Siddiq117, Federico Canzian118, Laurence N. Kolonel119, Loic Le Marchand119, Robert N. Hoover4, Mitchell J. Machiela4, Peter Kraft115, BPC3 (Breast and Prostate Cancer Cohort Consortium)120, The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium120, The COGS (Collaborative Oncological Gene-Environment Study) Consortium120, CAPS (Cancer of the Prostate in Sweden)120, PEGASUS (Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci)120, The GAME-ON/ELLIPSE Consortium120, David V. Conti6‡, Douglas F. Easton3‡, Fredrik Wiklund15‡, Stephen J. Chanock4‡, Brian E. Henderson6‡*, Zsofia Kote-Jarai5‡, Christopher A. Haiman6‡, Rosalind A. Eeles5,121‡. Prostate cancer meta-analysis of more than 145,000 men identifies 65 novel prostate cancer susceptibility loci. 2017 Nature Genetics
  4. Tyler M. Seibert, MD1,2, The PRACTICAL consortium* A genetic risk score to guide age-specific personalized prostate cancer screening. 2017 BMJ

Submitted

  1. Giuliano Di Pietro, Ph.D; Hung N Luu, PhD; Philippe E Spiess, MS; Wade Sexton, MD; Soreah Dickinson, MD; Alexander Parker, PhD; Park JY. Biomarkers and new therapeutic targets in renal cell carcinoma, 2017 World Journal of Urology 4/29/17
  2. Vasiliki I Dimitrakopoulou et al. Circulating vitamin D concentration and risk of seven cancers: a Mendelian randomization study. BMJ 2017 on 5/30/2017
  3. Fahad Mukhtar1, Paolo Boffetta2, Bashir Dabo1, Park JY, Thuan V. Tran4,5, Huong Thi-Thanh Tran4,5, Madison Whitney1, Harvey A. Risch6, Linh C. Le7, Wei Zheng8, Xiao-Ou Shu8, Hung N. Luu1,8. Disparities by Race, Age, and Sex in the Improvement of Survival for Lymphoma. BMJ 2017 submitted o 6/7/2017